Together, the studies on IDH mutant gliomas represent a shift in understanding the histogenesis of glial tumors and support a model where IDH mutant glioma subclasses share developmental programs and putative lineages of glial differentiation, but differ primarily by the genetic mutations and the number of macrophages and microglia in the TME [81]. The gene discussed is IDH2; the disease is central nervous system cancer.